We explore nearly 5,000 posts from Derek Lowe's In the Pipeline, map how his attention has moved across science, treatment modalities, and diseases since 2002, and put twelve questions about drug discovery to a retrieval model built on his own words.

We explore how AI is transforming synthetic biology by designing proteins never seen before in nature, examine various applications across therapeutics and gene therapy, and discuss the powerful data flywheel effect when AI is integrated with wet lab experiments.

We explore ten newly developed reporting guidelines for AI research in medicine, their potential impact on the field, and gaps between their intended and actual use by researchers and journals.

We explore why data engineering and clinical integration are major bottlenecks towards bringing AI tools to routine care, and identify other areas beyond the clinic more suited for AI development and deployment.

We explore the AI in pathology landscape through a group of 16 startups, AI applications beyond image interpretation, and how digitization and AI can mature alongside one another to produce tightly integrated solutions.

We explore a new emerging type of healthcare startups with AI offerings across medical specialities - a "multi-speciality AI vendor", and how ideas for clinical AI-centric products can be validated without AI.